Login / Signup
Yu Yan
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 2
Top Topics
Venous Thromboembolism
Emergency Department
Cell Cycle
Amyotrophic Lateral Sclerosis
Top Venues
Expert opinion on drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yu Yan
,
Bin Wu
,
Ling Wang
A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system.
Expert opinion on drug safety
(2024)
Yu Yan
,
Ling Wang
,
Yanling Yuan
,
Jiayue Xu
,
Yuxian Chen
,
Bin Wu
A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration adverse event reporting system data.
Expert opinion on drug safety
(2023)